Publicaciones en colaboración con investigadoras/es de University of Helsinki (10)

2022

  1. Characteristics of white blood cell count in acute lymphoblastic leukemia: A COST LEGEND phenotype–genotype study

    Pediatric Blood and Cancer, Vol. 69, Núm. 6

2021

  1. Author Correction: The SEQC2 epigenomics quality control (EpiQC) study (Genome Biology, (2021), 22, 1, (332), 10.1186/s13059-021-02529-2)

    Genome Biology

  2. Bacteriophage PRD1 as a nanoscaffold for drug loading

    Nanoscale, Vol. 13, Núm. 47, pp. 19875-19883

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  4. The SEQC2 epigenomics quality control (EpiQC) study

    Genome Biology, Vol. 22, Núm. 1

2018

  1. Diagnosis and management of pseudohypoparathyroidism and related disorders: First international Consensus Statement

    Nature Reviews Endocrinology, Vol. 14, Núm. 8, pp. 476-500

2017

  1. Rapalogs can promote cancer cell stemness in vitro in a Galectin-1 and H-ras-dependent manner

    Oncotarget, Vol. 8, Núm. 27, pp. 44550-44566

2016

  1. Cancer stem cell drugs target K-ras signaling in a stemness context

    Oncogene, Vol. 35, Núm. 40, pp. 5248-5262

2015

  1. Phenotypic Screening Identifies Protein Synthesis Inhibitors as H-Ras-Nanocluster-Increasing Tumor Growth Inducers

    Biochemistry, Vol. 54, Núm. 49, pp. 7212-7221

  2. Specific cancer-associated mutations in the switch III region of ras increase tumorigenicity by nanocluster augmentation

    eLife, Vol. 4, Núm. AUGUST2015, pp. 1-23